Bertram Yuh, M.D., M.I.S.M., M.S.H.C.P.M.

[email protected]
(877) 460-4673
Bertram Yuh, M.D., M.I.S.M., M.S.H.C.P.M.
Urologic Surgeon
Clinical Expertise
  • Robotic Surgery
  • Prostate Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Complex Oncology Surgery
  • Clinical Informatics
  • Data & Analytics
Research Area
  • Outcomes and Epidemiology
  • Robotic Surgery
  • Prostate Cancer
  • Bladder Cancer
  • Kidney Cancer
Other Languages Spoken
Mandarin
Spanish
Academic Appointments
  • Professor, Division of Urology and Urologic Oncology, Department of Surgery
  • Director, Urologic Oncology and Robotic Surgery Fellowship
  • Associate Chief Medical Information Officer
  • Clinical Documentation and Analytics Lead
Clinical Teams
Bladder Cancer
Enlarged Prostate
Kidney and Renal Cancer
Prostate Cancer
Surgery — Urology and Urologic Oncology
Testicular Cancer
Urology and Urologic Cancers Program
Additional Contacts
  • Referring Physicians/Colleagues
    (626) 218-0668

Bertram Yuh, M.D., M.I.S.M., M.S.H.C.P.M., specializes in robotic surgery to treat prostate, bladder and other urologic cancers. He received his medical degree from Case Western Reserve University, and master's degrees in information systems management and health care policy and management from Carnegie Mellon University. He completed a urology residency at State University of New York in Buffalo, New York, and a robotic surgery and urologic oncology fellowship at City of Hope. He joined City of Hope's Division of Urology and Urologic Oncology in 2010.  He is dual board certified in urology and clinical informatics.

He has been invited to speak nationally and internationally, and has joined in mission work in Guatemala and the Dominican Republic.

His clinical research focuses on improving outcomes for robotic surgery, particularly achieving better quality of life, cancer control, cost control and process flow. He is passionate about the benefits of robotic surgery compared to other treatments for prostate, bladder, and kidney cancer. He has authored over 70 peer-reviewed articles, reviews and chapters.

 

Location

Education & Experience

Degrees

  • 2001-2005, Case Western Reserve University, Cleveland, OH, M.D.

  • 2000-2002, Carnegie Melon University, Pittsburgh, PA, Master of Information Systems Management and M.S., Healthcare Policy and Management

  • 2000, University of Akron, Akron, OH, B.S., Natural Sciences, Summa Cum Laude

Fellowship

  • 2010-2011, Fellow, Urologic Oncology, City of Hope, Duarte, CA

Residency

  • 2006-2010, Resident, Urology, State University of New York, Buffalo, NY

  • 2005-2006, Resident, General Surgery, State University of New York, Buffalo, NY

Professional Experience

  • 2020-present, Professor, Division of Urology and Urologic Oncology, Department of Surgery, City of Hope, Duarte and Arcadia, CA

  • 2018-2020, Associate Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery, City of Hope, Duarte, CA

  • 2011-2018, Assistant Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery, City of Hope, Duarte, CA

Awards & Memberships

Memberships

  • Member, American Urological Association

  • Member, American Association of Clinical Urologists

  • Member, Endourologic Society

  • Member, Chinese American Medical Association of Southern California

  • Member, AUA Western Section

  • Member, Society of Urologic Oncology

Publications

  • Bosserman LD, Cianfrocca M, Yuh B, Yeon C, Chen H, Sentovich S, Polverini A, Zachariah F, Deaville D, Lee AB, Sedrak MS, King E, Gray S, Morse D, Glaser S, Bhatt G, Adeimy C, Tan T, Chao J, Nam A, Paz IB, Kruper L, Rao P, Sokolov K, Kulkarni P, Salgia R, Yamzon J, Johnson D. Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience. J Clin Med. 2021 Jan 7;10(2):188. doi: 10.3390/jcm10020188.PMID: 33430334
  • Salmi L, Dong ZJ, Yuh B, Walker J, DesRoches CM. Open Notes in Oncology: Patient vs. Oncology Clinician Views. Cancer Cell. 2020 Dec 14;38(6):767-768. doi: 10.1016/j.ccell.2020.09.016. Epub 2020 Oct 8. PMID: 33035494
  • Li R, Shinde A, Liu A, Glaser S, Lyou Y, Yuh B, Wong J, Amini A. Machine Learning-Based Interpretation and Visualization of Nonlinear Interactions in Prostate Cancer Survival. JCO Clin Cancer Inform. 2020 Jul; 4:637-646. doi: 10.1200/CCI.20.00002.PMID: 32673068
  • Hussein AA, Elsayed AS, Aldhaam NA, Jing Z, Peabody JO, Wijburg CJ, Wagner A, Canda AE, Khan MS, Scherr D, Schanne F, Maatman TJ, Kim E, Mottrie A, Aboumohamed A, Gaboardi F, Pini G, Kaouk J, Yuh B, Rha KH, Hemal A, Palou Redorta J, Badani K, Saar M, Stockle M, Richstone L, Roupret M, Balbay D, Dasgupta P, Menon M, Guru KA. A Comparative Propensity-Score Matched Analysis of Perioperative Outcomes of Intracorporeal versus Extracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Cancer Cell. 2020 Dec 14;38(6):767-768. doi: 10.1016/j.ccell.2020.09.016. Epub 2020 Oct 8. PMID: 33035494
  • Banapour P, Yuh B, Chenam A, Shen JK, Ruel N, Han ES, Kim JY, Maghami EG, Pigazzi A, Raz DJ, Singh GP, Wakabayashi M, Woo Y, Fong Y, Lau CS. Readmission and complications after robotic surgery: experience of 10,000 operations at a comprehensive cancer center. J Robot Surg. 2020 Apr 10. doi: 10.1007/s11701-020-01077-4. [Epub ahead of print] PMID: 32277400
  • Sampath S, Frankel P, Vecchio BD, Ruel N, Yuh B, Liu A, Tsai T, Wong J. Stereotactic body radiation therapy to the prostate bed: results of a phase I dose escalation trial. Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):537-545. doi: 10.1016/j.ijrobp.2019.11.005. Epub 2019 Nov 13. PMID: 31733323
  • Aldhaam NA, Elsayed AS, Jing Z, Richstone L, Wagner AA, Rha KH, Yuh B, Palou J, Khan MS, Menon M, Roupret M, Balbay D, Hosseini A, Wiklund P, Gaboardi F, Maatman TJ, Mottrie A, Wijburg C, Stöckle M, Hemal A, Kim E, Kaouk J, Hussein AA, Guru KA. Neoadjuvant Chemotherapy Is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Utilization from the IRCC. J Urol. 2020 Jan;203(1):57-61. doi: 10.1097/JU.0000000000000445. Epub 2019 Jul 17. PMID: 31600114 JIF: 5.647
  • Yuh BE, Kwon YS, Shinder BM, Singer EA, Jang TL, Kim S, Stein MN, Mayer T, Ferrari A, Lee N, Parikh RR, Ruel N, Kim WJ, Horie S, Byun SS, Ahlering TE, Kim IY. Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer. Prostate Int. 2019 Sep;7(3):102-107. doi: 10.1016/j.prnil.2018.10.002. Epub 2018 Oct 25. PMID: 31485434
  • Shen JK, Jamnagerwalla J, Yuh BE, Bassett MR, Chenam A, Warner JN, Zhumkhawala A, Yamzon JL, Whelan C, Ruel NH, Lau CS, Chan KG. Real-time indocyanine green angiography with the SPY fluorescence imaging platform decreases benign ureteroenteric strictures in urinary diversions performed during radical cystectomy. Ther Adv Urol. 2019 Apr 4;11:1756287219839631. doi: 10.1177/1756287219839631. eCollection 2019 Jan-Dec. PMID: 31057669
  • Audenet F, Sfakianos JP, Waingankar N, Ruel NH, Galsky MD, Yuh BE, Gin GE. A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging. Urol Oncol. 2019 Feb;37(2):116-122. doi: 10.1016/j.urolonc.2018.11.011. Epub 2018 Dec 1. PMID:30509868
  • Chenam A, Ruel N, Pal S, Barlog J, Lau C, Wilson T, Yuh B. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer. Can J Urol. 2018 Jun;25(3):9340-9348. PMID: 29900823 JIF: 1.039
  • Yuh B, Chan K, Wilson T. Robotic Cystectomy-Moving from Innovation to Measurable Impact. Eur Urol. 2018 Oct; 74(4):472-473. doi: 10.1016/j.eururo.2018.05.028. Epub 2018 Jun 10. PMID: 29898834
  • Eng OS, Raoof M, Blakely AM, Yu X, Lee SJ, Han ES, Wakabayashi MT, Yuh B, Lee B, Dellinger TH. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer. J Surg Oncol. 2018 Jul; 118(1):121-126. doi: 10.1002/jso.25120. Epub 2018 Jun 7. PMID: 29878375
  • Dinizo M, Shih W, Kwon YS, Eun D, Reese A, Giusto L, Trabulsi EJ, Yuh B, Ruel N, Marchalik D, Hwang J, Kundu SD, Eggener S, Kim IY. Multi-institution analysis of racial disparity among African American men eligible for prostate cancer active surveillance. Oncotarget. 2018 Apr 20;9(30):21359-21365. doi: 10.18632/oncotarget.25103. eCollection 2018 Apr 20. PMID: 29765545
  • Yuh, B, Kwon YS, Shinder BM, Singer EA, Jang TL, Kim S, Kim IY. (2018). Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer. Prostate International.
  • Hussein AA, May PR, Jing Z, Ahmed YE, Wijburg CJ, Canda AE, Dasgupta P, Shamim Khan M, Menon M, Peabody JO, Hosseini A, Kelly J, Mottrie A, Kaouk J, Hemal A, Wiklund P, Guru KA; Collaborators, Wagner A, Saar M, Redorta JP, Stockle M, Richstone L, Gaboardi F, Badani K, Rha KH, Khan H, Kawa O, Schanne F, Polakis V, Weizer A, Scherr D, Pini G, Tan WS, Maatman TJ, Kibel A,Yuh B, Peak TC. Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. J Urol. 2017 Dec 21. pii: S0022-5347(17)78161-X. doi: 10.1016/j.juro.2017.12.045.
  • Chenam A, Parihar JS, Ruel N, Pal S, Avila Y, Yamzon J, Lau C,Yuh B. Lymph Node Positive Prostate Cancer after Robotic Prostatectomy and Extended Pelvic Lymphadenectomy. J Robot Surg. 2017 Sep 13. doi: 10.1007/s11701-017-0751-8.
  • Chenam A, Yuh B, Zhumkhawala A, Ruel N, Chu W, Lau C, Chan K, Wilson T, Yamzon J. Prospective Randomized Non-Inferiority Trial of Pelvic Drain Placement versus No Pelvic Drain Placement after Robot-Assisted Radical Prostatectomy. BJU Int. 2017 Sep 5. doi: 10.1111/bju.14010.
  • Jensen L,Yuh B, Wong JYC, Schultheiss T, Cheng J, Ruel N, Twardowski P, Sampath S. Outcomes and toxicity of 313 prostate cancer patients receiving helical tomotherapy after radical prostatectomy. Adv Radiat Oncol. 2017 Aug 8; 2(4):597-607. doi: 10.1016/j.adro.2017.08.004.
  • Pal SK, Pham A, Vuong W, Liu X, Lin Y, Ruel N, Yuh BE, Chan K, Wilson T, Lerner SP, McConkey D, Jove R, Liang W. Prognostic Significance of Neutrophilic Infiltration in Benign Lymph Nodes in Patients with Muscle-invasive Bladder Cancer. Eur Urol Focus. 2017 Feb; 3(1):130-135. doi: 10.1016/j.euf.2016.03.003. Epub 2016 Mar 25.
  • Hussein AA, May PR, Ahmed YE, Saar M, Wijburg CJ, Richstone L, Wagner A, Wilson T, Yuh B, Redorta JP, Dasgupta P, Kawa O, Khan MS, Menon M, Peabody JO, Hosseini A, Gaboardi F, Pini G, Schanne F, Mottrie A, Rha KH, Hemal A, Stockle M, Kelly J, Tan WS, Maatman TJ, Poulakis V, Kaouk J, Canda AE, Balbay MD, Wiklund P, Guru KA. Development of a Patient and Institutional-Based Model for Estimation of Operative Times for Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. BJU Int. 2017 Jun 16. doi: 10.1111/bju.13934.
  • Kim DK, Parihar JS, Kwon YS, Kim S, Shinder B, Lee N, Farber N, Ahlering T, Skarecky D, Yuh B, Ruel N, Kim WJ, Rha KH, Kim IY. Risk of complications and urinary incontinence following Cytoreductive prostatectomy: a multi-institutional study. Asian J Androl. 2017 Apr 25. doi: 10.4103/1008-682X.196852. PMID:28440262 (JIF: 2.644)
  • Gin GE, Ruel NH, Parihar JS, Warner JN, Yuh BE, Yamzon J, Wilson TG, Lau CS, Chan KG. Ureteroenteric anastomotic revision as initial management of stricture after urinary diversion. Int J Urol. 2017 May; 24(5):390-395. doi: 10.1111/iju.13323. Epub 2017 Mar 12. PMID: 28295645
  • Gin GE, Ruel NH, Kardos SV, Sfakianos JP, Uchio E, Lau CS, Yuh BE. Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma. Urol Oncol. 2016 Dec 29. pii: S1078-1439(16)30405-7. doi: 10.1016/j.urolonc.2016.11.017. [Epub ahead of print] PMID: 28041996 (JIF: 0.818)
  • Hussein AA, Saar M, May PR, Wijburg CJ, Richstone L, Wagner A, Wilson T, Yuh B, Redorta JP, Dasgupta P, Shamim Khan M, Menon M, Peabody JO, Hosseini A, Gaboardi F, Mottrie A, Rha KH, Hemal A, Stockle M, Kelly J, Maatman TJ, Canda AE, Wiklund P, Guru KA. Early Oncologic Failure after Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. J Urol. 2016 Dec 16. pii: S0022-5347(16)31985-1. (JIF: 4.700)
  • Chennamsetty A, Zhumkhawala A, Tobis S, Ruel N, Lau C, Yamzon J, Wilson T, Yuh B. Lymph Node Fluorescence during Robot-Assisted Radical Prostatectomy with Indocyanine Green - A Prospective Dosing Analysis. Clin Genitourin Cancer. 2016 Nov 16. pii: S1558-7673(16)30323-8. (JIF: 2.599)/li>
  • Ma X, Tang K, Yang C, Wu G, Xu N, Wang M, Zeng X, Hu Z, Song R, Yuh B, Wang Z, Ye Z. Bladder neck preservation improves time to continence after radical prostatectomy: a systematic review and meta-analysis. Oncotarget. 2016 Sep 13. doi: 10.18632/oncotarget.11997. (JIF: 2.272)
  • Yuh B. Re: Erectile Function Recovery after Radical Prostatectomy in Men with High-Risk Features. J Urol. 2016 Aug;196(2):512-3.
  • Gin G, Parihar G, Yuh B, Yamzon J, Lau C, Chan KG. PD-12-03 Primary Ureteroenteric Anastomotic Revision after urinary Diversion. J. Urol April 2016; 195(4): e293-e294. DOI: 10.1016/j.juro.2016.02.898.
  • Kardos SV, Chan KG, Yuh B, Yamzon J, Ruel NH, Zachariah F, Lau CS, Crocitto L. PD02-02 Enhanced recovery after surgery and care coordination pathway at city of hope: Decreased length of stay, readmissions, and complications. J. Urol April 2016; 195(4s): e51. DOI: 10.1016/j.juro.2016.02.2076.
  • Yuh B, Liu A, Beatty R, Jung A, Wong JY. Focal therapy using magnetic resonance image-guided focused ultrasound in patients with localized prostate cancer. J Ther Ultrasound. 2016 Mar 11; 4:8. doi: 10.1186/s40349-016-0054-y. eCollection 2016.
  • Pal SK, Pham A, Vuong W, Liu X, Lin Y, Ruel N, Yuh B, Chan K, Wilson T, Lerner S, McConkey D, Jove R, Liang W. Prognostic Significance of Neutrophilic Infiltration in Benign Lymph Nodes in Patients with Muscle-invasive Bladder Cancer. EU Focus. 2016 Mar. Published online: 26 March 2016
  • Yuh B, Yu X, Raytis J, Lew M, Fong Y, Lau C. Use of a mobile tower-based robot-The initial Xi robot experience in surgical oncology. J Surg Oncol. 2016 Jan; 113(1):5-7. doi: 10.1002/jso.24094. Epub 2015 Nov 25. (JIF: 3.151)
  • Raytis J, Yuh B, Lau C, Fong Y, Lew M. Anesthetic Implications of Robotically Assisted Surgery with the Da Vinci Xi Surgical Robot. Open Journal of Anesthesiology 06(08):115-118 · January 2016
  • Wittig K, Ruel N, Barlog J, Crocitto L, Chan K, Lau C, Wilson T, Yuh B. Critical Analysis of Hospital Readmission and Cost Burden After Robot-Assisted Radical Cystectomy. J Endourol. 2016 Jan;30(1):83-91. doi: 10.1089/end.2015.0438. Epub 2015 Sep 25. (JIF: 2.107)
  • Pal SK, Lin YI, Yuh B, DeWalt K, Kazarian A, Vogelzang N, Nelson RA. Conditional Survival in de novo Metastatic Urothelial Carcinoma. PLoS One. 2015 Aug 26;10(8): e0136622. doi: 10.1371/journal.pone.0136622. (JIF: 3.057)
  • Kwon YS, Ha YS, Modi PK, Salmasi A, Parihar JS, Patel N, Faiena I, May M, Lee DI, Llukani E, Patrick T, Rha KH, Ahlering T, Skarecky D, Ahn H, Choi SK, Park S, Jeon SS, Ou YC, Eun D, Manucha V, Albala D, Badani K, Yuh B, Ruel N, Kim TH, Kwon TG, Marchalik D, Hwang J, Kim WJ, Kim IY. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study. BMC Urol. 2015 Aug 1; 15:79. doi: 10.1186/s12894-015-0070-1.
  • Raza SJ, Wilson T, Peabody JO, Wiklund P, Scherr DS, Al-Daghmin A, Dibaj S, Khan MS, Dasgupta P, Mottrie A, Menon M, Yuh B, Richstone L, Saar M, Stoeckle M, Hosseini A, Kaouk J, Mohler JL, Rha KH, Wilding G, Guru KA. Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Eur Urol. 2015 May 15. pii: S0302-2838(15)00323-1. doi: 10.1016/j.eururo.2015.04.021.
  • Zhumkhawala A., Kozinn S., Chan KG., Lau C., Ruel N., Yamzon J., Yuh B., Kawachi M., Wilson T. MP67-18 A Decade of Robotic Cystectomy: surgical characteristics and oncologic outcomes. J. Urol April 2015; 193(4): e856-e857. DOI: 10.1016/j.juro.2015.02.2501.
  • Bourque J., Chan KG., Wilson T., Lau C., Yuh B., Yamzon J. MP64-08 Establishing a care coordination Pathway for bladder cancer Cystectomy patients. J. Urol. 2015 April; 193(4): e800-e801. DOI: 10.1016/j.juro.2015.02.2319

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
5.0
Show respect for what you say
4.9
Recommend this provider office
4.9
Provider explain in way you understand
4.9
Provider listen carefully to you
4.9
Spend enough time with you
4.9
Rate provider 0-10
4.8
Know important info medical history
07/15/24
Very good. - Verified patient
07/15/24
Love it. - Verified patient
07/15/24
Clear and precise. - Verified patient
06/27/24
Outstanding. - Verified patient
06/19/24
Excellent clarity. No issues at all. - Verified patient